RIGEL PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-03
- RIGEL PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.00%.
- RIGEL PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.10%.
- RIGEL PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -1.50%, a 250.00% decline from fiscal 2022.
- RIGEL PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 1.00%, a 62.96% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-03 | |
| 2024-12-31 | -0.10% 10-K · filed 2026-03-03 | |
| 2023-12-31 | -1.50% 10-K · filed 2026-03-03 | 1.50% 10-K · filed 2024-03-05 |
| 2022-12-31 | 1.00% 10-K · filed 2025-03-04 | |
| 2021-12-31 | 2.70% 10-K · filed 2024-03-05 | |
| 2020-12-31 | 4.60% 10-K · filed 2023-03-07 | |
| 2019-12-31 | 1.50% 10-K · filed 2022-03-01 | |
| 2018-12-31 | 0.20% 10-K · filed 2021-03-02 | |
| 2017-12-31 | -1.80% 10-K · filed 2020-02-27 | |
| 2016-12-31 | 1.30% 10-K · filed 2019-02-28 | -1.00% 10-K · filed 2017-03-07 |
| 2015-12-31 | 2.70% 10-K · filed 2017-03-07 | |
| 2014-12-31 | 1.70% 10-K · filed 2017-03-07 | |
| 2013-12-31 | -3.90% 10-K · filed 2016-03-08 | |
| 2012-12-31 | -2.10% 10-K · filed 2015-03-03 | |
| 2011-12-31 | 0.40% 10-K · filed 2014-03-04 | |
| 2010-12-31 | -0.40% 10-K · filed 2013-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |